- Home
- ACRV vs AEF Comparison
ACRV vs AEF Comparison
Compare ACRV & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- AEF
- Stock Information
- Founded
- ACRV 2018
- AEF 1989
- Country
- ACRV United States
- AEF United States
- Employees
- ACRV N/A
- AEF N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- AEF Finance/Investors Services
- Sector
- ACRV Health Care
- AEF Finance
- Exchange
- ACRV Nasdaq
- AEF Nasdaq
- Market Cap
- ACRV 247.8M
- AEF 286.2M
- IPO Year
- ACRV 2022
- AEF N/A
- Fundamental
- Price
- ACRV $7.93
- AEF $5.25
- Analyst Decision
- ACRV Strong Buy
- AEF
- Analyst Count
- ACRV 5
- AEF 0
- Target Price
- ACRV $22.60
- AEF N/A
- AVG Volume (30 Days)
- ACRV 44.0K
- AEF 92.5K
- Earning Date
- ACRV 11-13-2024
- AEF 01-01-0001
- Dividend Yield
- ACRV N/A
- AEF 7.13%
- EPS Growth
- ACRV N/A
- AEF N/A
- EPS
- ACRV N/A
- AEF 0.57
- Revenue
- ACRV N/A
- AEF N/A
- Revenue This Year
- ACRV N/A
- AEF N/A
- Revenue Next Year
- ACRV N/A
- AEF N/A
- P/E Ratio
- ACRV N/A
- AEF $8.86
- Revenue Growth
- ACRV N/A
- AEF N/A
- 52 Week Low
- ACRV $3.19
- AEF $4.40
- 52 Week High
- ACRV $11.90
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- ACRV 48.40
- AEF 37.33
- Support Level
- ACRV $7.69
- AEF $5.34
- Resistance Level
- ACRV $8.66
- AEF $5.55
- Average True Range (ATR)
- ACRV 0.34
- AEF 0.06
- MACD
- ACRV -0.00
- AEF -0.02
- Stochastic Oscillator
- ACRV 22.64
- AEF 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. It invests in the public equity and fixed income markets of Chile. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, Private Equity, telecommunication services, healthcare, real estate and industrials.